Search results
Results from the WOW.Com Content Network
Cipla sells active pharmaceutical ingredients to other manufacturers as well as pharmaceutical and personal care products, [20] including the anti-depressant escitalopram oxalate, lamivudine, and fluticasone propionate. [21] Cipla is the world's largest manufacturer of antiretroviral drugs. [20] [22]
India's revenue from pharmaceutical exports was $25.3 billion in the 2022-2023 financial year. [7] In terms of the global market, India currently holds an accountable share and is known as the pharmacy of the world. [9] The country is the largest global supplier of generic medicine. [10] India produces more than 50% the world's vaccines. [11]
This list of oldest companies in India includes brands and companies, excluding associations and educational, governmental, or religious organisations. To be listed, a brand or company name must remain, either in whole or in part, since inception and should have been established before 1947 and be currently operational.
Cipla, India's No.3 generic drugmaker by sales, reported a better-than-expected quarterly profit on Friday, boosted by strength in its key domestic and North American businesses. The results come ...
Cipla's launch of remdesivir in late June, along with subsequent launches by others, has helped ease supply bottlenecks in India, Cipla's Global Chief Financial Officer, Kedar Upadhye, told Reuters.
HYDERABAD/BENGALURU (Reuters) -Cipla, India's third-largest generics drugmaker by sales, beat first-quarter profit estimates on Friday as it reported higher sales in its North America market ...
It had 1,247 distributors, 142 super stockists and 3,175 sub stockists to support the sales team in India. Its distributors and sub stockists cover around 650,000 retailers in India. GCPL has linked its major distributors in India through a system called 'Sampark', a collaborative planning, forecasting and replenishment system with its ERP ...
BENGALURU (Reuters) -Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of albuterol sulfate inhalation aerosol due to a "container defect". "The company is initiating a ...